1/5
In terms of that government FOMO, the other highlighted uses on that #AVCT slide, point towards "GP surgery" and "Testing station."
Both of which orientate themselves towards UK Gov.
Parking that rather large potential GP surgery market for a moment.
2/5
For anyone doubting AVCTs ability to win significant orders from the UK Gov, just consider for a moment, how much more efficient UK Gov testing sites could become, when a test result can be achieved in c. 10 mins, without the need to employ an expensive piece of kit.
3/5
How much quicker the stations could process their backlogs and how fewer miles people would have to drive, to get a test full stop.
How likely is it that the UK Gov would turn that opportunity down and let it be sold overseas? Possible but minimal in my view.
4/5
Most importantly of all, at this late stage in the product's development.
After the LSTM have been "evaluating the performance of prototype lateral flow tests" for nearly 2 months, how good must the data be, for AVCT to be talking up localised workplace testing...
5/5
...and testing station roll out, in direct competition to for instance, mobile PCR testing etc etc.
Certainly goo enough to make it a valid mass screening tools, which is where we are clearly heading with this now.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.